Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07286292

Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

The objective of this study is to evaluate the safety, tolerability, efficacy profile, and effect on growth and development of vorasidenib in pediatric particip…

Location not specified10 participantsStarted 2026-03-15

Treatment: Vorasidenib